Denali Therapeutics Inc (DNLI)
Investing Cash Flow
-$104.08M
Quarterly · Period ending: · USD
DNLI Investing Cash Flow
Latest reported-$104.08Mperiod ending
Latest reported-$104.08Mperiod ending
DNLI Quarterly Cash from Investing (-$25.37M → -$104.08M)
Quarterly investing cash flow
High-resolution chart · PNG
DNLI investing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -104,078,000 | |
| 94,460,000 | |
| 20,768,000 | |
| 57,830,000 | |
| 157,935,000 | |
| 18,748,000 | |
| 172,207,000 | |
| 93,655,000 | |
| 98,569,000 | |
| -453,187,000 | |
| 73,047,000 | |
| 100,909,000 | |
| 168,067,000 | |
| -92,715,000 | |
| -127,559,000 | |
| 15,419,000 | |
| 88,631,000 | |
| -117,878,000 | |
| -40,750,000 | |
| -53,008,000 | |
| 97,537,000 | |
| -25,405,000 | |
| -367,340,000 | |
| -212,122,000 | |
| -30,411,000 | |
| -13,333,000 | |
| 42,385,000 | |
| 49,493,000 | |
| 63,881,000 | |
| -8,047,000 | |
| -61,403,000 | |
| 44,727,000 | |
| 30,528,000 | |
| -301,274,000 | |
| -95,149,000 | |
| 16,526,000 | |
| 22,074,000 | |
| 15,383,000 | |
| -18,947,000 | |
| -149,308,000 | |
| -25,374,500 | |
| -25,374,500 |